Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$736
|
$696B |
12.4x |
29.8x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$176
|
$457B |
5.0x |
13.6x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$208
|
$432B |
7.3x |
16.0x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$85
|
$239B |
3.7x |
8.3x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$290
|
$204B |
5.8x |
11.0x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$189B |
3.0x |
7.7x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$115
|
$162B |
5.6x |
11.4x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$47
|
$133B |
2.8x |
9.4x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$387
|
$94.4B |
8.1x |
24.5x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$155
|
$74.0B |
7.8x |
18.1x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$451
|
$57.6B |
18.9x |
126.2x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$588
|
$57.5B |
4.1x |
11.6x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$132
|
$26.7B |
61.4x |
-27.4x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$26.1B |
1.8x |
6.1x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$137
|
$23.9B |
2.5x |
7.3x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$27
|
$19.7B |
N/A |
-58.4x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$84
|
$14.0B |
3.0x |
14.3x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$137
|
$13.0B |
4.9x |
20.4x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$18
|
$12.6B |
2.8x |
14.2x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$125
|
$11.3B |
2.7x |
9.6x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$309
|
$10.9B |
3.5x |
6.6x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$10.7B |
1.7x |
5.5x |
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$49
|
$10.4B |
27.2x |
-22.5x |
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$57
|
$10.2B |
3.3x |
12.0x |
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$38
|
$9.7B |
4.3x |
12.1x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$73
|
$9.5B |
7.8x |
12.0x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$105
|
$9.1B |
3.4x |
-6.3x |
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$425
|
$8.8B |
13.9x |
-27.0x |
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$70
|
$7.0B |
8.7x |
N/A |
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$14
|
$6.7B |
N/A |
N/A |
Rhythm Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$101
|
$6.6B |
39.4x |
-31.9x |
Perrigo
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$24
|
$6.5B |
1.5x |
8.6x |
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$121
|
$6.0B |
11.0x |
-33.6x |
Legend Biotech
|
United States of America |
Drug Development & Therapeutics
|
$35
|
$5.9B |
6.5x |
-44.6x |
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$42
|
$5.9B |
7.2x |
-14.2x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$5.5B |
1.9x |
8.3x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$25
|
$5.2B |
2.2x |
-1.4x |
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$37
|
$5.0B |
932.3x |
-5.4x |
Avidity Biosciences
|
United States of America |
Drug Development & Therapeutics
|
$47
|
$4.9B |
489.1x |
-9.0x |
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$38
|
$4.6B |
77.6x |
-7.9x |
TG Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$28
|
$4.5B |
9.0x |
40.6x |
Nuvalent
|
United States of America |
Drug Development & Therapeutics
|
$75
|
$4.4B |
N/A |
-12.7x |
Merus
|
United States of America |
Drug Development & Therapeutics
|
$67
|
$4.4B |
93.9x |
-13.9x |
Prestige Consumer Healthcare
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$66
|
$4.2B |
3.7x |
11.2x |
Ascentage Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$43
|
$4.0B |
39.6x |
-45.3x |
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$29
|
$3.8B |
2.6x |
9.9x |
Mirum Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$74
|
$3.7B |
8.4x |
-96.1x |
Lantheus Holdings
|
United States of America |
Medical Imaging & Diagnostics,
Drug Development & Therapeutics
|
$56
|
$3.7B |
2.5x |
6.1x |
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$12
|
$3.7B |
140.3x |
-3.4x |
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$3.6B |
6.0x |
17.8x |
ACADIA Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$3.6B |
3.5x |
25.1x |
Apellis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$28
|
$3.6B |
4.2x |
286.4x |
Krystal Biotech
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$147
|
$3.6B |
10.2x |
28.2x |
CRISPR Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$55
|
$3.5B |
100.9x |
-6.7x |
Arcellx
|
United States of America |
Drug Development & Therapeutics
|
$70
|
$3.5B |
48.5x |
-17.2x |
Soleno Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$70
|
$3.5B |
38.8x |
N/A |
Akero Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$48
|
$3.1B |
N/A |
-9.8x |
MoonLake
|
United States of America |
Drug Development & Therapeutics
|
$55
|
$3.1B |
N/A |
-15.4x |
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$34
|
$3.0B |
791.4x |
-9.1x |
Protagonist Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$57
|
$3.0B |
15.6x |
850.7x |
Metsera
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$33
|
$3.0B |
N/A |
N/A |
Ligand Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$160
|
$2.9B |
14.5x |
40.4x |
Procaps Group
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$1
|
$2.7B |
N/A |
N/A |
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$2.6B |
34.1x |
N/A |
Kymera Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$44
|
$2.6B |
36.8x |
-9.4x |
Amicus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$8
|
$2.5B |
4.3x |
35.9x |
Xenon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$39
|
$2.5B |
505.6x |
-7.6x |
ANI Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$92
|
$2.4B |
3.2x |
12.2x |
Liquidia
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$28
|
$2.4B |
48.0x |
N/A |
Ultragenyx
|
United States of America |
Drug Development & Therapeutics
|
$30
|
$2.4B |
3.9x |
-5.4x |
Arrowhead Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$21
|
$2.4B |
3.5x |
182.4x |
Sarepta Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$18
|
$2.3B |
1.2x |
-102.3x |
PTC Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$49
|
$2.3B |
1.6x |
4.7x |
BioCryst Pharma
|
United States of America |
Drug Development & Therapeutics
|
$9
|
$2.2B |
4.0x |
44.3x |
Kiniksa Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$34
|
$2.2B |
3.9x |
44.3x |
Tarsus Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$59
|
$2.2B |
6.4x |
-31.2x |
Viking Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$2.1B |
N/A |
-8.7x |
NewAmsterdam Pharma Co
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$25
|
$2.1B |
57.5x |
N/A |
Celcuity
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$49
|
$2.0B |
N/A |
-13.9x |
Phibro Animal Health
|
United States of America |
Drug Development & Therapeutics
|
$33
|
$2.0B |
1.6x |
11.1x |
Supernus Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$44
|
$2.0B |
3.0x |
11.3x |
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$65
|
$2.0B |
N/A |
N/A |
Immunovant
|
United States of America |
Drug Development & Therapeutics
|
$15
|
$1.9B |
N/A |
-4.1x |
Certara
|
United States of America |
Health Data & Analytics,
Drug Development & Therapeutics
|
$11
|
$1.9B |
4.6x |
14.7x |
Adaptive Biotech
|
United States of America |
Pharma Diagnostics & Analytics,
Drug Development & Therapeutics
|
$13
|
$1.8B |
8.6x |
-35.7x |
Amphastar Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$30
|
$1.8B |
2.5x |
6.7x |
Ocular Therapeutix
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$12
|
$1.8B |
31.6x |
-7.9x |
Collegium Pharmaceutical
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$39
|
$1.8B |
2.6x |
4.2x |
Vericel
|
United States of America |
Regenerative Medicine,
Drug Development & Therapeutics
|
$36
|
$1.8B |
7.0x |
28.1x |
Arcutis Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$16
|
$1.8B |
6.4x |
-27.1x |
Catalyst Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$20
|
$1.8B |
3.3x |
7.0x |
Crinetics Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$31
|
$1.8B |
425.0x |
-4.1x |
Apogee Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$38
|
$1.8B |
N/A |
-6.8x |
Harmony Biosciences Hldgs
|
United States of America |
Drug Development & Therapeutics
|
$37
|
$1.7B |
2.2x |
6.8x |
Recursion Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Bioinformatics,
Vertical AI Applications
|
$5
|
$1.7B |
24.8x |
-3.0x |
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$12
|
$1.6B |
N/A |
-7.0x |
Travere Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$17
|
$1.6B |
4.7x |
-13.8x |
BGM Group
|
United States of America |
Drug Development & Therapeutics
|
$8
|
$1.6B |
N/A |
N/A |
Harrow
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$39
|
$1.6B |
6.3x |
26.2x |
Biohaven
|
United States of America |
Drug Development & Therapeutics
|
$16
|
$1.6B |
746.1x |
-1.9x |